Latest Breaking News On - Uniao quimica farmaceutica nacional - Page 1 : comparemela.com

Brazil s national sanitary watchdog Anvisa will analyze the research protocol within 72 hours © Stringer/TASS RIO DE JANEIRO, December 30. /TASS/. Brazilian pharmaceutical company Uniao quimica, a partner of the Russian Direct Investment Fund (RDIF), has filed a request to the country’s national sanitary watchdog Anvisa for Phase 3 clinical trials of the Sputnik V vaccine. Late on Tuesday (29/12), Anvisa received a request for permission to hold Phase 3 clinical trials of the Sputnik V vaccine. The request was filed by the Uniao quimica lab. … Anvisa will analyze the research protocol within 72 hours, the watchdog’s press service said late on Tuesday. The agency reaffirmed that national trials are obligatory for obtaining state registration for any medicine in Brazil.

Uniao quimica farmaceutica nacionalSinovac biotechBrazil national health surveillance agency anvisaRussian direct investment fundNational health surveillance agencyஊனியஓ குவிமிகா பார்மசேதிக்க நேஸீயநல்ரஷ்ய நேரடி முதலீடு நிதி